Building Smart Pricing Strategies to Secure Reimbursement for Gene Therapy in Common Conditions

• Understanding how payers evaluate value when multiple therapies exist for the same disease
• Learning how coverage decisions, rebates, and clinical trade-offs impact pricing outcomes
• Exploring how to align internal teams on pricing strategy early to avoid reimbursement delays and maximize launch success

Speakers:

Roelof Rongen

Chief Executive Officer & Board Director

Adolore BioTherapeutics